NCT00514033View on ClinicalTrials.gov

A Post-marketing Safety Study of GSK Bio IPV Vaccine (PoliorixTM) in Korean Children

CompletedOBSERVATIONAL

Enrollment

349

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

July 31, 2011

Study Completion Date

July 31, 2011

Conditions

Poliomyelitis

Interventions

BIOLOGICAL

Poliomyelitis vaccine (inactivated) -PoliorixTM

Deep intramuscular injections for the primary vaccination and booster vaccination.

Trial Locations (1)

Unknown

GSK Investigational Site, Seoul

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY